Exact Sciences Corp

詳細情報 Exact Sciences Corp 企業名

Exact Sciences Corporation is a provider of cancer screening and diagnostic tests. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. It is focusing its research and development efforts on three main areas: Colorectal Cancer Screening Test Development, MCED Test Development and MRD Test Development. Its products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, OncoExTra Test, and Riskguard Test. Its flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.

企業情報

企業コードEXAS

会社名Exact Sciences Corp

上場日Jan 30, 2001

設立日1995

最高経営責任者「CEO」Mr. Kevin T. Conroy

従業員数6900

証券種類Ordinary Share

決算期末Jan 30

本社所在地5505 Endeavor Lane

都市MADISON

証券取引所NASDAQ Capital Market Consolidated

国United States of America

郵便番号53719

電話番号16082845700

ウェブサイトhttps://www.exactsciences.com/

企業コードEXAS

上場日Jan 30, 2001

設立日1995

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Kevin T. Conroy

Chairman of the Board, President, Chief Executive Officer

1.14M

-20.54%

Ms. Katherine S. (Kay) Zanotti

Independent Director

72.76K

+3.10%

Mr. Daniel J. (Dan) Levangie

Independent Director

34.31K

+18.67%

Ms. Shacey Petrovic

Independent Director

28.90K

+22.97%

Mr. Brian Baranick

Executive Vice President, General Manager - Precision Oncology

23.26K

+0.94%

Ms. Leslie L. Trigg

Independent Director

17.17K

+80.75%

Ms. Kimberly J. (Kim) Popovits

Independent Director

16.38K

+156.47%

Mr. Aaron Bloomer

Chief Financial Officer, Executive Vice President

13.84K

--

Mr. Michael J. (Mike) Barber, M.D.

Independent Director

13.14K

+121.18%

Mr. James E. Doyle

Lead Independent Director

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Kevin T. Conroy

Chairman of the Board, President, Chief Executive Officer

1.14M

-20.54%

Ms. Katherine S. (Kay) Zanotti

Independent Director

72.76K

+3.10%

Mr. Daniel J. (Dan) Levangie

Independent Director

34.31K

+18.67%

Ms. Shacey Petrovic

Independent Director

28.90K

+22.97%

Mr. Brian Baranick

Executive Vice President, General Manager - Precision Oncology

23.26K

+0.94%

Ms. Leslie L. Trigg

Independent Director

17.17K

+80.75%

収益内訳

通貨: USD更新時刻: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Commercial

1.31B

47.44%

Medicare Parts B & C

964.10M

34.95%

Other

296.74M

10.76%

International

189.09M

6.85%

COVID 19 testing

0.00

0.00%

地域別USD

会社名

収益

比率

United States (Country)

2.57B

93.15%

Outside of united states

189.09M

6.85%

事業別

地域別

事業別USD

会社名

収益

比率

Commercial

1.31B

47.44%

Medicare Parts B & C

964.10M

34.95%

Other

296.74M

10.76%

International

189.09M

6.85%

COVID 19 testing

0.00

0.00%

株主

更新時刻: Sat, Jun 21

株主統計

種類

株主統計

比率

Fidelity Management & Research Company LLC

12.80%

Capital World Investors

9.45%

The Vanguard Group, Inc.

9.31%

Wellington Management Company, LLP

6.63%

BlackRock Institutional Trust Company, N.A.

4.07%

Other

57.74%

株主統計

比率

Fidelity Management & Research Company LLC

12.80%

Capital World Investors

9.45%

The Vanguard Group, Inc.

9.31%

Wellington Management Company, LLP

6.63%

BlackRock Institutional Trust Company, N.A.

4.07%

Other

57.74%

種類

株主統計

比率

Investment Advisor

51.79%

Investment Advisor/Hedge Fund

36.26%

Hedge Fund

4.35%

Research Firm

2.51%

Bank and Trust

1.35%

Pension Fund

1.13%

Individual Investor

0.92%

Sovereign Wealth Fund

0.56%

Private Equity

0.36%

Other

0.78%

機関投資家保有株

更新時刻: Mon, Jan 20

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q1

1394

200.40M

106.36%

-205.96K

2024Q4

1411

200.72M

108.09%

-225.66K

2024Q3

1375

190.82M

103.28%

-5.17M

2024Q2

1358

185.25M

100.40%

+6.59M

2024Q1

1347

168.41M

92.78%

-6.10M

2023Q4

1356

165.31M

91.41%

-11.01M

2023Q3

1337

167.70M

92.83%

-6.22M

2023Q2

1354

166.38M

92.24%

-10.65M

2023Q1

1343

167.01M

92.90%

-8.56M

2022Q4

1337

163.71M

92.15%

-9.28M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Fidelity Management & Research Company LLC

18.85M

10.15%

-712.35K

-3.64%

Dec 31, 2024

Capital World Investors

17.54M

9.44%

+1.70M

+10.71%

Dec 31, 2024

The Vanguard Group, Inc.

16.95M

9.12%

-741.47K

-4.19%

Dec 31, 2024

Wellington Management Company, LLP

12.06M

6.49%

-2.27M

-15.86%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

7.66M

4.13%

+245.10K

+3.30%

Dec 31, 2024

State Street Global Advisors (US)

6.23M

3.36%

-447.40K

-6.70%

Dec 31, 2024

T. Rowe Price Associates, Inc.

5.62M

3.03%

+2.48M

+78.79%

Dec 31, 2024

Fidelity Institutional Asset Management

1.90M

1.02%

-182.61K

-8.76%

Dec 31, 2024

Mackenzie Investments

2.92M

1.57%

+1.51M

+107.71%

Dec 31, 2024

Geode Capital Management, L.L.C.

3.12M

1.68%

+16.83K

+0.54%

Dec 31, 2024

詳細を見る

51.920USD

Exact Sciences Corp

51.920

概要

企業名